Gastric and Esophageal
- Breast, Esophagus, Larynx, Lip, Oral Cavity and Pharynx, Lung, Other Urinary, Phase I, ThyroidFirst-In-Human, Open-Label, Dose Escalation and Expansion Trial to Evaluate the Safety, Pharmacokinetics and Efficacy of GEN1106 in Participants With Solid Tumors
- Colon, Lung, Other Digestive Organ, Pancreas, Phase IPhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Colon, Esophagus, Larynx, Lip, Oral Cavity and Pharynx, Lung, Other Digestive Organ, Pancreas, Phase I, Rectum, Small Intestine, StomachA Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors